Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PHIO PHARMACEUTICALS CORP.

(PHIO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Phio Pharmaceuticals Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021

05/13/2021 | 05:08pm EDT

Phio Pharmaceuticals Corp. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced operating loss was USD 3.638 million compared to USD 2.356 million a year ago. Net loss was USD 3.407 million compared to USD 2.351 million a year ago. Basic loss per share from continuing operations was USD 0.32 compared to USD 1.33 a year ago.


© S&P Capital IQ 2021
All news about PHIO PHARMACEUTICALS CORP.
09/16US Stocks Mostly Lower Thursday After Surprise Retail Sales Gain, Rise in Job..
MT
09/16US Stocks End Mostly Lower as Investors Weigh Surprise Retail Sales Gain Agai..
MT
09/16Health Care Stocks Largely Sitting Out Markets Recovery This Afternoon
MT
09/16Health Care Stocks Muted in Premarket Thursday
MT
09/16PHIO PHARMACEUTICALS : Presents Data at ESMO 2021 Demonstrating Persistent Anti-..
PR
09/10PHIO PHARMACEUTICALS : HCW 23rd Annual Global Investment Conference Presentation
PU
09/06PHIO PHARMACEUTICALS : to Participate in the H.C. Wainwright 23rd Annual Global ..
AQ
09/03PHIO PHARMACEUTICALS : to Participate in the H.C. Wainwright 23rd Annual Global ..
PR
08/31PHIO PHARMACEUTICALS : Announces Upcoming Data Presentation at the ESMO Virtual ..
PR
08/18NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
More news
Analyst Recommendations on PHIO PHARMACEUTICALS CORP.
More recommendations
Financials (USD)
Sales 2021 - - -
Net income 2021 -14,1 M - -
Net Debt 2021 - - -
P/E ratio 2021 -1,98x
Yield 2021 -
Capitalization 29,5 M 29,5 M -
Capi. / Sales 2021 -
Capi. / Sales 2022 0,59x
Nbr of Employees 10
Free-Float 99,7%
Chart PHIO PHARMACEUTICALS CORP.
Duration : Period :
Phio Pharmaceuticals Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PHIO PHARMACEUTICALS CORP.
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 2,18 $
Average target price 6,00 $
Spread / Average Target 175%
EPS Revisions
Managers and Directors
Gerrit Dispersyn President, Chief Executive Officer & Director
Caitlin Kontulis Secretary, VP-Finance & Administration
Robert J. Bitterman Chairman
Simon Fricker Vice President-Research
James Cardia Vice President-Business Operations
Sector and Competitors
1st jan.Capi. (M$)
PHIO PHARMACEUTICALS CORP.-18.96%30
MODERNA, INC.321.80%175 368
LONZA GROUP AG34.92%61 973
IQVIA HOLDINGS INC.43.91%49 541
CELLTRION, INC.-25.63%31 848
SEAGEN INC.-12.32%27 670